In Vitro Diagnostics – IVD News
Epigenomics Receives Notice of FDA Pending Approval
Epigenomics Receives FDA Notification About Status of Pending Approval Decision for Epi proColon® Berlin, Germany, January 8, 2016 – Epigenomics AG, Berlin, Germany, (Frankfurt Prime Standard: ECX; ISIN: DE000A11QW50) the German-American cancer molecular diagnostics company, today announced that the U.S. Food and Drug Administration (FDA) has informed the Company that the already submitted and available…
Read MoreCuretis IPO
Curetis AG / Curetis IPO priced at EUR 10.00 per Share; raises EUR 40 million . Holzgerlingen, Germany, November 10, 2015 — Curetis N.V.[1] (the “Company” and, together with Curetis AG, “Curetis“), a developer of next-level molecular diagnostic solutions, today announces the completion of its initial public offering, which was launched on October 28, 2015…
Read MoreEpigenomics Update at AMP 2015 Annual Meeting
http://www.epigenomics.com/en/news-investors/news-media/press-releases/latest-news/article/epigenomics-ag-gibt-ein-update-ueber-bluttests-zur-krebsfrueherkennung-auf-der-jahrestagung-2015-der.html
Read MoreGBC Attends 2014 ASM Conference
Global BioClinical (GBC) attended the 2014 American Society for Microbiology (ASM) meeting in Boston. MAhttp://gm.asm.org/
Read More2013 ICAAC Poster
GBC Attended the 2013 Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Denver, Colorado September 9 – 13, 2013 Click here for Poster PDF: [wpdm_file id=8] Poster Title: Evaluation of a Molecular Multiplex Test For Detection of Respiratory Microorganism and Antibiotic Resistance Genes in Clinical Specimens Authors: M. Malczynski1, M. Klein2, N. Mucci3, K. Schwarzer2, A.…
Read MoreBiopreservation and Biobanking Publication
Neil R. Mucci of GBC Leads caHUB Committee in Developing, Summarizing and Publishing Recommendations that Promote Availability of Biospecimens for Research SEATTLE, April 25, 2013 Global BioClinical (GBC) is pleased to announce the publication of an article in the April 2013 issue of Biopreservation and Biobanking titled: Meeting Research Needs with Postmortem Biospecimen Donation: Summary of Recommendations for…
Read MoreGBC Supports Curetis AG Trial in U.S.
Curetis AG Initiates Clinical Trial in the U.S. Towards FDA Clearance December 6, 2012 – 10:44:28 – Prospective Multi-Center Trial to Enroll Over 2,000 Clinical Samples (live-PR.com) – Holzgerlingen, Germany, December 6, 2012 — Curetis AG today announced the start of a clinical trial of its Unyvero™ System and the corresponding LRT (lower respiratory tract)…
Read MoreGlobal BioClinical Welcomes Jennifer Maas
Experienced Clinical Research Manager Joins Seattle-based Contract Consulting and Clinical Research Services Company SEATTLE, May 31, 2012 /PRNewswire-iReach/ — Global BioClinical (GBC) is pleased to announce the addition of Jennifer Maas to the corporate team. Ms. Maas has joined GBC as a Senior Consultant and Clinical Operations Manager. Formerly a Clinical Research Manager at Epigenomics, Inc., Ms. Maas joins GBC…
Read MoreGlobal BioClinical Launches New Website
New Site Describes Expertise-Based Clinical Research Services Including Consulting, Business, Trials, and Biospecimen Services SEATTLE, April 4, 2012 /PRNewswire-iReach/ — Global BioClinical (GBC) the Seattle-based contract consulting and clinical research services company has launched a new website at www.globalbioclinical.com. The site offers expanded information on the company, services offered, partner registration, new search capabilities, and links to common professional and social…
Read More